Cureety

Soy profesional

Profesional sanitario

Evidencia clínica, detalles de integración y especificaciones de producto para equipos de oncología.

Soy paciente o cuidador

Paciente o cuidador

Información sobre Cureety como tu compañero diario durante el proceso de tratamiento.

Feasability

Patients enrolled in the program

Participating center(s) across the study

Effectiveness of electronic patient reporting outcomes, by a digital telemonitoring platform, for prostate cancer care: the Protecty study

A prospective, observational, monocentric study to measure compliance with the use of Cureety in patients with prostate cancer.

Evolution of patients' compliance after 6 months, based on their health quality

High remote monitoring compliance of 72% during the first month, 59% at 8 months.

Patients divided in 2 groups based on the 1st month of monitoring: 'Healthy' (87%) and 'Poor Health' (13%).

29% increase of progression-free survival at 6 months in the 'Healthy' group (p = 0.17).

14% increase of overall survival at 6 months in the 'Healthy' group (p = 0.15).

Helissey et al., 2023, Front. Digit. Health